Docusate Sodium and Sennosides
NDC 62993-0002, Docusate Sodium and Sennosides, tablet, from Morepen Laboratories Limited.
- Product NDC
- 62993-0002
- Status
- Listed
- Labeler
- Morepen Laboratories Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62993-0002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCUSATE SODIUM50 mg/1
- SENNOSIDES8.6 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62993-0002-1 | 62993000201 | 30 TABLET in 1 BOTTLE (62993-0002-1) |
| 62993-0002-2 | 62993000202 | 60 TABLET in 1 BOTTLE (62993-0002-2) |
| 62993-0002-3 | 62993000203 | 100 TABLET in 1 BOTTLE (62993-0002-3) |
| 62993-0002-4 | 62993000204 | 1000 TABLET in 1 BOTTLE (62993-0002-4) |
| 62993-0002-5 | 62993000205 | 3000 TABLET in 1 BOTTLE (62993-0002-5) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62993-0002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62993-0002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62993-0002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.